← Evidence map

ReviewCNS drugs2004

The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment.

Ceri J PhillipsPubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this paperpooled itcites it

The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment. | OpenQuestion